{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:37:12Z","timestamp":1774528632537,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1305700"],"award-info":[{"award-number":["2016YFC1305700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.pcd.2021.12.009","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T21:49:08Z","timestamp":1639777748000},"page":"168-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Short-term effects of lifestyle intervention in the reversion to normoglycemia in people with prediabetes"],"prefix":"10.1016","volume":"16","author":[{"given":"Yuxiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianshuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-0933","authenticated-orcid":false,"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2021.12.009_bib0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2019"},{"key":"10.1016\/j.pcd.2021.12.009_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","article-title":"Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000","volume":"24","author":"Forouhi","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0015","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2021.12.009_bib0020","first-page":"S9","article-title":"Impaired glucose tolerance\u2014prevalence and conversion to NIDDM","volume":"13","author":"Harris","year":"1996","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pcd.2021.12.009_bib0030","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00125-009-1386-8","article-title":"Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population","volume":"52","author":"Xu","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2021.12.009_bib0035","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/dme.13113","article-title":"Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis","volume":"33","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2021.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0050","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstrom","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2021.12.009_bib0055","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"Investigators","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2021.12.009_bib0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0065","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Control","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2021.12.009_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00125-010-1985-4","article-title":"Long-term effect of rosiglitazone and\/or ramipril on the incidence of diabetes","volume":"54","author":"D.O. Investigators","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2021.12.009_bib0080","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2021.12.009_bib0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pcd.2018.11.017","article-title":"Efficacy of lifestyle interventions in the reversion to normoglycemia in Korean prediabetics: one-year results from a randomised controlled trial","volume":"13","author":"Nah","year":"2019","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2021.12.009_bib0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00592-018-1249-1","article-title":"Dietary changes in a diabetes prevention intervention among people with prediabetes: the Diabetes Community Lifestyle Improvement Program trial","volume":"56","author":"Ford","year":"2019","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.pcd.2021.12.009_bib0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc17-2685","article-title":"Long-term outcomes of lifestyle intervention to prevent diabetes in American Indian and Alaska Native communities: the special diabetes program for Indians diabetes prevention program","volume":"41","author":"Jiang","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2021.12.009_bib0100","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2337\/dc06-0560","article-title":"Effect of weight loss with lifestyle intervention on risk of diabetes","volume":"29","author":"Hamman","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2021.12.009_bib0105","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.2337\/dc09-0676","article-title":"Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1)","volume":"32","author":"Snehalatha","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2021.12.009_bib0110","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.54.8.2404","article-title":"Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin","volume":"54","author":"Kitabchi","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2021.12.009_bib0115","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/jc.2004-1782","article-title":"Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes","volume":"90","author":"Giannopoulou","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pcd.2021.12.009_bib0120","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2337\/dc09-0523","article-title":"Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program","volume":"32","author":"Perreault","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2021.12.009_bib0125","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/diabetes.52.7.1738","article-title":"Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance","volume":"52","author":"Basu","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2021.12.009_bib0130","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2021.12.009_bib0135","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","author":"G. Diabetes Prevention Program Research","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2021.12.009_bib0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-012-2752-5","article-title":"Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)","volume":"56","author":"Lindstrom","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2021.12.009_bib0145","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2021.12.009_bib0150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991821002254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991821002254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:02Z","timestamp":1761696002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991821002254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1751991821002254"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2021.12.009","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term effects of lifestyle intervention in the reversion to normoglycemia in people with prediabetes","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2021.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}